Omega Flex, Inc. 2015 First-Quarter Form 10-Q Summary
Business Context and Reporting Period
Omega Flex manufactures flexible metal hose and accessories, including TracPipe and TracPipe CounterStrike flexible gas piping, serving construction, manufacturing, petrochemical, pharmaceutical and other markets. Operations are managed as one segment, with manufacturing in Exton, Pennsylvania and Banbury, United Kingdom. This unaudited report covers the three months ended March 31, 2015, compared with the same period in 2014.
Financial Performance and Position
| Metric | Q1 2015 | Q1 2014 | Change |
|---|---|---|---|
| Net sales | $20.973 million | $16.589 million | 26.4% increase |
| Gross profit | $12.390 million | $9.279 million | 33.5% increase |
| Gross margin | 59.1% | 55.9% | Up 3.2 percentage points |
| Operating profit | $4.707 million | $3.265 million | 44.2% increase |
| Operating margin | 22.4% | 19.7% | Up 2.7 percentage points |
| Net income attributable to Omega Flex | $3.143 million | $2.195 million | 43.2% increase |
| Basic and diluted EPS | $0.31 | $0.22 | Increase of $0.09 |
| Net cash used in operating activities | $0.839 million | $1.341 million | $0.502 million improvement |
Management attributed the sales increase to strong unit growth despite construction statistics indicating a slight market decline. Gross margin benefited from a modest price increase and factory efficiencies, which more than offset higher strip-metal costs. Selling expense increased to $3.775 million from $3.123 million, primarily because commissions rose with sales, while general and administrative expense increased to $3.277 million from $2.187 million, largely due to $953,000 of additional legal and product-liability defense costs.
At March 31, 2015, cash and cash equivalents were $16.526 million, down from $22.585 million at December 31, 2014. Total assets were $48.447 million, compared with $55.138 million at year-end, primarily reflecting the cash dividend and normal first-quarter working-capital payments. Total liabilities were $11.391 million, versus $21.169 million at December 31, 2014. Shareholders’ equity was $37.056 million.
The Company used $0.197 million for capital expenditures and $4.945 million for financing activities, consisting of the January 5, 2015 payment of a $0.49-per-share special dividend. The Company had no outstanding borrowings under its unsecured $15 million revolving credit facility, which matures December 31, 2019, and was in compliance with its debt covenants. The facility was available for working capital and dividends.
Material Changes Versus the Prior Comparable Period
- Sales, gross profit, operating profit and net income increased substantially year over year.
- Gross and operating margins improved despite higher raw-material costs.
- General and administrative expense increased 49.8%, principally because of higher legal and product-liability defense costs.
- Operating cash use improved by $502,000, although cash flow remained negative because of first-quarter payments for accrued incentives, compensation and taxes.
- The Company paid a $4.945 million special dividend in January 2015; no comparable dividend payment occurred in the first quarter of 2014.
- Cash declined by approximately $6.059 million from year-end, while accounts payable and accrued compensation fell as prior-year obligations were paid.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide formal numerical revenue or earnings guidance. Management expects existing cash and cash equivalents to be sufficient for anticipated investing needs for at least the next 12 months. Cash generally declines early in the year because of payments for promotional incentives, incentive compensation and taxes, and has historically accumulated later in the year.
- Pending product-liability claims are covered by insurance subject to deductibles or self-insured retentions generally ranging from $25,000 to $250,000 per claim. Aggregate potential exposure for current open claims was estimated at approximately $4.5 million, although the ultimate liability cannot be estimated.
- Product-liability and legal-cost accruals were $437,000 at March 31, 2015, down from $582,000 at December 31, 2014.
- Two putative class actions were dismissed in 2014, primarily for lack of jurisdiction, but litigation and future claims could adversely affect results, liquidity and insurance costs.
- The Company carried a $213,000 long-term asset related to restitution from an insurance-premium fraud; the amount ultimately recoverable remains unclear.
- One customer represented more than 10% of net sales and accounts receivable, creating customer-concentration risk. Sales are also concentrated in the United States.
- Foreign-currency translation produced a $99,000 after-tax comprehensive loss, and foreign-currency transaction expense increased to $46,000 from $8,000.
- The Company granted 10,460 phantom stock units during the quarter and recorded approximately $213,000 of phantom-stock compensation income. The related liability was $482,000 at March 31, 2015.
- The Company was evaluating the effect of ASU 2014-09, Revenue from Contracts with Customers, scheduled to become effective in fiscal 2018; no transition method had been selected.
Important Facts for Investors to Verify
- Whether the strong sales growth and improved margins continue after the first quarter, particularly given construction-market softness and higher raw-material costs.
- The trend in legal and product-liability defense costs and the ultimate exposure from pending claims.
- The timing and recoverability of the $213,000 restitution-related asset.
- The sustainability of cash generation after the special dividend and recurring early-year working-capital outflows.
- The impact of the significant customer concentration and foreign-currency movements.
- The eventual accounting impact and transition method selected for the new revenue-recognition standard.